AB
Amphix Bio, Inc.
SEC filingBiotechnology · Chicago, IL
Amount raised$10.3Msold at filing
Total offering$12.5M$2.2M still open
Investors in the raise9count reported to the SEC
FiledDec 19, 2025first sale Dec 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Samuel StuppExecutive Officer, Director
Kok-Wai WongDirector
Stephen R WilsonDirector
John PotocsnakDirector
Nicholas SatherExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.